The a2 Milk Company (A2M) 2017年年度报告「ASX」.pdf

1、Annual Report 20162017a2 Platinum infant formula revenue up84%ANZ EBITDA Sales growth across US and UK markets Development of a broader nutritional products strategyNew focus on emerging marketsof Group revenue spent on marketing,IP and R&D$155m+83%8.4%China revenue more than doubled and EBITDA+258%

2、3.5%China infant formula consumption share(Kantar)Focus on Chinas evolving regulatory regimeGroup Revenue+56%and EBITDA+159%Acquired 8.2%of Synlait Milk Limited3.6-20140.0-20140.0-20144.8-20150.3-20152.1-201554.6-20164.4-201630.4-2016141.2-201712.7-2017$550m-2017$141m-201712.7c-2017$91m-201790.6-201

3、7EBITDA1(NZ$million)Earnings per share(cents per share)Total revenue(NZ$million)Net profit after tax(NZ$million)FY17 highlights2.4 11.197.3-20140.9 41.7112.5-201518.1 214.4120.3-201629.6 394.0125.9-2017Other Infant formula Liquid milk011 Earnings before interest,tax,depreciation and amortisation(EBI

4、TDA)is a non GAAP measure.However,the Company believes that it assists in providing investors with a comprehensive understanding of the underlying performance of the business.A reconciliation of EBITDA to net profit after tax is shown on page 96ContentsAbout usChairmans letterCEOs year in reviewCorp

5、orate governanceFinancial statementsOther information0412142648880302Based on the early vision of founder Dr Corran McLachlan,we are passionate about pioneering the understanding of the natural benefits of products containing only the A2 beta-casein protein type and in doing so hope to inspire peopl

6、e to enjoy healthier lives.We develop consistently high quality branded dairy-based nutritional products that are A1 protein-free,underpinned by an integrated portfolio of intellectual property and growing scientific evidence.Over recent years we have diversified from a predominately Australian fres